Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Orbis Flying Eye Hospital Marks 20 Years of Partnership with Macau
04 Sep 2026
PR Newswire Association LLC.
Workforce shortages and limited public hospital capacity remain major barriers to stroke care in the Philippines, new report finds
02 Sep 2026
PR Newswire Association LLC.
Singapore has cut stroke mortality by up to six-fold since the 1990s, but public awareness remains the final hurdle, new report finds
02 Sep 2026
PR Newswire Association LLC.
Delays before patients reach stroke centres remain a major barrier to timely treatment in Malaysia, new report finds
02 Sep 2026
PR Newswire Association LLC.
Despite nationwide basic stroke treatment coverage, delays accessing advanced stroke care in Vietnam vary by region, new report finds
02 Sep 2026
PR Newswire Association LLC.
Delays Before Patients Reach Stroke Centers Still Hinder Timely Treatment Across Southeast Asia, Siemens Healthineers Report Finds
02 Sep 2026
PR Newswire Association LLC.
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD
01 Sep 2026
PR Newswire Association LLC.
Siemens Healthineers showcases its AI-powered technological innovations to redefine healthcare delivery in Southeast Asia
01 Sep 2026
PR Newswire Association LLC.
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
31 Aug 2026
PR Newswire Association LLC.
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
12 Aug 2026
PR Newswire Association LLC.
NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
11 Aug 2026
GlobeNewswire
Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
05 Aug 2026
PR Newswire Association LLC.
Green Science Alliance Made Quantum Dot from Sargassum and Sargassum Waste
05 Aug 2026
GlobeNewswire
Alira Health Establishes Annabel de Maria Memorial Scholarship to Inspire the Next Generation of Healthcare Leaders
29 Jul 2026
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
PR Newswire Association LLC.
C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework
25 Jun 2026
GlobeNewswire
Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma
06 Aug 2026
GlobeNewswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
04 Aug 2026
GlobeNewswire
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
31 Jul 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026
27 Jul 2026
GlobeNewswire
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24 Jul 2026
GlobeNewswire
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
23 Jul 2026
GlobeNewswire
Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health
22 Jul 2026
GlobeNewswire
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
21 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
17 Jul 2026
Upcoming Events All Events
- September 2026
- Rockville: BioHealth Capital Region Forum & Investment Conference
- Seoul: Korea Life Science Week
- Boston: RESI Boston 2026